University of Warwick   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Warwick United Kingdom (1965)

Organization Overview

First Clinical Trial
2007
NCT00497809
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Dept. of Oncology, University Hospital, Clifford Bridge Road, Walsgrave, Coventry | Prof. Janet Dunn | The ARDEN NET Centre, ENETS CoE | University Hospital Coventry | University Hospital Coventry and Warwickshire NHS Trust | University Hospital Coventry UK | University Hospitals Coventry and Warwickshire NHS Trust | University Hospitals Coventry & Warwickshire NHS Trust | University Hospitals of Coventry and Warwickshire | University of Warwick | Warwick Research Services

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abortion, Missed (Phase 3)

Abortion, Spontaneous (Phase 3)

Altitude Sickness (Phase 1)

Amyotrophic Lateral Sclerosis (Phase 3)

Arthritis (Phase 4)

Brain Edema (Phase 1)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Squamous Cell (Phase 3)

Cardiovascular Diseases (Phase 3)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Critical Illness (Phase 3)

Edema (Phase 1)

Glucose Intolerance (Phase 2)

Kidney Diseases (Phase 3)

Motor Neuron Disease (Phase 3)

Multiple Myeloma (Phase 2)

Multiple Sclerosis (Phase 2)

Multiple Sclerosis, Chronic Progressive (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Neutropenia (Phase 2)

Ovarian Neoplasms (Phase 2)

Renal Insufficiency (Phase 2)

Renal Insufficiency, Chronic (Phase 3)

Sclerosis (Phase 2)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 22
  • # of Trial APIs: 39